In silico analysis of Oncomine datasets showed that KIAA1199 upregulation occurs in various cancers including colorectal cancer, breast cancer, gastric cancer, lymphoma, and pancreatic cancer (Fig. 2a). Here, CEMIP is linked to breast carcinoma.